Figure 2From: Split Course Hyperfractionated Accelerated Radio-Chemotherapy (SCHARC) for patients with advanced head and neck cancer: Influence of protocol deviations and hemoglobin on overall survival, a retrospective analysisKaplan Meier Analysis of survival probability. Comparison between patients who completed the SCHARC-scheme (n = 40, black line) and patients with modified therapy (n = 24, blue line). The Cox regression analysis showed a statistically significant difference between the groups (p = 0.01).Back to article page